Skip to content

EVO - Evotec SE - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchE

Evotec SE ADR

EVO · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

E

EVOEvotec SE ADR

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $4.27
52-wk low: $1.89
Prev close: $2.79
Mkt cap: $703.7M
Fwd P/E: 53.5x
Beta: 1.26

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$413K

CI
Citadel
Ken Griffin · Q1 2026 13F
$218K
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -27.5%
Forward P/E: 53.48
Market cap: $704M

Valuation

P/S0.98
P/B0.88

Quality

Operating margin-62.3%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: EVO
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $703.67M
Beta: 1.26

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

1.0x

P/B

0.9x

Profit margin

-27.5%

Op margin

-62.3%

ROE

-26.1%

$64K

position

QR

Qube Research

Q4 2025 13F

$40K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for EVO

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

ROE

-26.1%

ROA-5.4%

Growth

Beta1.26